LON:DPH - Dechra Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 2,750 -36.00 (-1.29 %)
(As of 05/22/2018 04:00 PM ET)
Previous CloseGBX 2,750
Today's RangeGBX 2,746 - GBX 2,802
52-Week RangeGBX 1,622 - GBX 2,720
Volume225,252 shs
Average Volume282,452 shs
Market Capitalization£2.73 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Dechra Pharmaceuticals (LON:DPH)

Dechra Pharmaceuticals logoDechra Pharmaceuticals plc develops, manufactures, sells, and markets veterinary pharmaceuticals and related products for veterinarians worldwide. The company operates through the European Pharmaceuticals, the North American Pharmaceuticals, and the Pharmaceuticals Research and Development segments. It offers various endocrinology, dermatology and care, anesthesia and analgesia, cardiovascular disease, ophthalmology, and equine medicine products; food producing animal antimicrobials; poultry vaccines; and pet diets. The company markets and distributes veterinary pharmaceuticals and equipment; provides financial services; and manufactures human and veterinary pharmaceutical products for third party customers. Dechra Pharmaceuticals plc markets its products through wholesaler and distributor networks. The company was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Receive DPH News and Ratings via Email

Sign-up to receive the latest news and ratings for DPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolLON:DPH
CUSIPN/A
Phone+44-1606-814730

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.15%
Return on Equity9.08%
Return on Assets4.25%

Miscellaneous

EmployeesN/A
Outstanding Shares93,420,000

Dechra Pharmaceuticals (LON:DPH) Frequently Asked Questions

What is Dechra Pharmaceuticals' stock symbol?

Dechra Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "DPH."

How often does Dechra Pharmaceuticals pay dividends? What is the dividend yield for Dechra Pharmaceuticals?

Dechra Pharmaceuticals declared a dividend on Monday, February 26th. Shareholders of record on Thursday, March 8th will be paid a dividend of GBX 7.33 per share on Friday, April 6th. This represents a yield of 0.29%. The ex-dividend date of this dividend is Thursday, March 8th. The official announcement can be viewed at this link. View Dechra Pharmaceuticals' Dividend History.

What price target have analysts set for DPH?

6 analysts have issued twelve-month target prices for Dechra Pharmaceuticals' shares. Their forecasts range from GBX 1,550 to GBX 2,640. On average, they expect Dechra Pharmaceuticals' share price to reach GBX 2,121.17 in the next year. View Analyst Ratings for Dechra Pharmaceuticals.

Who are some of Dechra Pharmaceuticals' key competitors?

Who are Dechra Pharmaceuticals' key executives?

Dechra Pharmaceuticals' management team includes the folowing people:
  • Mr. Ian D. Page, CEO, MD & Exec. Director (Age 57)
  • Mr. Richard John Cotton BA Hons, FCMA, CFO & Director (Age 57)
  • Dr. Anthony Gerard Griffin, MD of Dechra Veterinary Products for Europe & Exec. Director (Age 55)
  • Ms. Andrea Dodds, Group Marketing Director
  • Ms. Katy Clough, Group HR Director

Has Dechra Pharmaceuticals been receiving favorable news coverage?

Headlines about DPH stock have trended somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dechra Pharmaceuticals earned a media sentiment score of 0.24 on Accern's scale. They also gave news coverage about the company an impact score of 45.85 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Dechra Pharmaceuticals?

Shares of DPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Dechra Pharmaceuticals' stock price today?

One share of DPH stock can currently be purchased for approximately GBX 2,750.

How big of a company is Dechra Pharmaceuticals?

Dechra Pharmaceuticals has a market capitalization of £2.73 billion.

How can I contact Dechra Pharmaceuticals?

Dechra Pharmaceuticals' mailing address is 24 Cheshire Business Park Cheshire Avenue, NORTHWICH, CW9 7UA, United Kingdom. The company can be reached via phone at +44-1606-814730.


MarketBeat Community Rating for Dechra Pharmaceuticals (DPH)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  206 (Vote Outperform)
Underperform Votes:  254 (Vote Underperform)
Total Votes:  460
MarketBeat's community ratings are surveys of what our community members think about Dechra Pharmaceuticals and other stocks. Vote "Outperform" if you believe DPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dechra Pharmaceuticals (LON:DPH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Dechra Pharmaceuticals in the last 12 months. Their average twelve-month price target is GBX 2,121.17The high price target for DPH is GBX 2,640 and the low price target for DPH is GBX 1,550. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 2,121.17GBX 2,121.17GBX 2,121.17GBX 1,784

Dechra Pharmaceuticals (LON:DPH) Consensus Price Target History

Price Target History for Dechra Pharmaceuticals (LON:DPH)

Dechra Pharmaceuticals (LON:DPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/26/2018Royal Bank of CanadaReiterated RatingSector performGBX 2,400View Rating Details
2/26/2018Numis SecuritiesReiterated RatingAddGBX 2,640View Rating Details
1/30/2018Jefferies GroupUpgradeBuyGBX 2,221 ➝ GBX 2,631View Rating Details
7/11/2017Stifel NicolausReiterated RatingHoldGBX 1,550View Rating Details
7/6/2017InvestecReiterated RatingBuyGBX 1,840View Rating Details
7/6/2017N+1 SingerReiterated RatingBuyGBX 1,666View Rating Details
4/20/2017Panmure GordonReiterated RatingUnder ReviewView Rating Details
2/24/2017FinnCapReiterated RatingUnder ReviewView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Dividends

Dechra Pharmaceuticals (LON:DPH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2018GBX 7.330.29%3/8/20183/8/20184/6/2018
9/4/2017GBX 15.330.74%10/26/201710/26/201711/17/2017
2/27/2017GBX 6.110.38%3/9/20173/9/20174/7/2017
9/5/2016GBX 12.910.92%10/27/201610/27/201611/18/2016
2/22/2016GBX 5.550.47%3/10/20163/10/20164/6/2016
9/7/2015GBX 11.821.26%10/29/201510/29/201511/20/2015
9/8/2014GBX 10.651.4%11/6/201411/6/201411/21/2014
2/25/2014GBX 4.750.68%3/12/20143/12/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Dechra Pharmaceuticals (LON DPH) Insider Trading and Institutional Ownership History

Insider Trading History for Dechra Pharmaceuticals (LON:DPH)

Dechra Pharmaceuticals (LON DPH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2017Ian PageInsiderSell54,910GBX 2,024£1,111,378.40
6/21/2017Ian PageInsiderSell134,500GBX 1,927£2,591,815
5/2/2017Ian PageInsiderSell1,630GBX 1,715£27,954.50
3/21/2017Tony GriffinInsiderSell3,500GBX 1,676£58,660
11/30/2016Tony GriffinInsiderSell17,133GBX 1,292£221,358.36
6/3/2016Rice,TonyInsiderBuy20,000GBX 1,141£228,200
3/21/2016Nesmes,Anne-FrancoiseInsiderSell3,100GBX 1,208£37,448
9/9/2015Nesmes,Anne-FrancoiseÂInsiderSell18,319GBX 940£172,198.60
(Data available from 1/1/2013 forward)

Headlines

Dechra Pharmaceuticals (LON DPH) News Headlines

Source:
DateHeadline
Dechra Pharmaceuticals (DPH) Receives Consensus Rating of "Buy" from AnalystsDechra Pharmaceuticals (DPH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - May 22 at 1:34 AM
Dechra Pharmaceuticals (DPH) Given Consensus Rating of "Buy" by AnalystsDechra Pharmaceuticals (DPH) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - April 27 at 1:06 AM
Stifel Nicolaus Reiterates Hold Rating for Dechra Pharmaceuticals (DPH)Stifel Nicolaus Reiterates Hold Rating for Dechra Pharmaceuticals (DPH)
www.americanbankingnews.com - April 19 at 4:34 PM
Dechra Pharmaceuticals (DPH) PT Raised to GBX 1,868 at Jefferies GroupDechra Pharmaceuticals (DPH) PT Raised to GBX 1,868 at Jefferies Group
www.americanbankingnews.com - April 9 at 2:58 PM
Dechra Pharmaceuticals (DPH) Receives Average Recommendation of "Buy" from AnalystsDechra Pharmaceuticals (DPH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 2 at 1:30 AM
Dechra Pharmaceuticals (DPH) Rating Reiterated by Jefferies GroupDechra Pharmaceuticals (DPH) Rating Reiterated by Jefferies Group
www.americanbankingnews.com - March 27 at 10:22 PM
Dechra Pharmaceuticals (DPH) Upgraded to Buy by Jefferies GroupDechra Pharmaceuticals (DPH) Upgraded to Buy by Jefferies Group
www.americanbankingnews.com - March 26 at 4:53 PM
Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business UpdateKane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update
finance.yahoo.com - March 22 at 9:44 AM
Dechra Pharmaceuticals plc (DPH) Receives Average Rating of "Buy" from AnalystsDechra Pharmaceuticals plc (DPH) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - March 8 at 1:24 AM
What does Dechra Pharmaceuticals plc’s (LON:DPH) Balance Sheet Tell Us About Its Future?What does Dechra Pharmaceuticals plc’s (LON:DPH) Balance Sheet Tell Us About Its Future?
finance.yahoo.com - March 4 at 5:20 PM
Dechra Pharmaceuticals plc Declares Dividend of GBX 7.33 (DPH)Dechra Pharmaceuticals plc Declares Dividend of GBX 7.33 (DPH)
www.americanbankingnews.com - March 3 at 2:30 PM
Dechra Pharmaceuticals (DPH) "Add" Rating Reiterated at Numis SecuritiesDechra Pharmaceuticals' (DPH) "Add" Rating Reiterated at Numis Securities
www.americanbankingnews.com - February 26 at 11:00 PM
Royal Bank of Canada Reaffirms Sector perform Rating for Dechra Pharmaceuticals (DPH)Royal Bank of Canada Reaffirms Sector perform Rating for Dechra Pharmaceuticals (DPH)
www.americanbankingnews.com - February 26 at 2:24 PM
Veterinary Group Dechra - 2018 Interim ResultsVeterinary Group Dechra - 2018 Interim Results
finance.yahoo.com - February 26 at 9:23 AM
Does Dechra Pharmaceuticals plc’s (LON:DPH) Recent Track Record Look Strong?Does Dechra Pharmaceuticals plc’s (LON:DPH) Recent Track Record Look Strong?
finance.yahoo.com - February 21 at 9:35 AM
Dechra Pharmaceuticals plc (DPH) Given Average Recommendation of "Buy" by BrokeragesDechra Pharmaceuticals plc (DPH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 11 at 1:28 AM
Dechra Pharmaceuticals (DPH) Rating Reiterated by Numis SecuritiesDechra Pharmaceuticals (DPH) Rating Reiterated by Numis Securities
www.americanbankingnews.com - February 3 at 6:34 PM
Royal Bank of Canada Lowers Dechra Pharmaceuticals (DPH) to Sector PerformerRoyal Bank of Canada Lowers Dechra Pharmaceuticals (DPH) to Sector Performer
www.americanbankingnews.com - February 1 at 11:43 AM
Dechra to buy Dutch firms AST Farma, Le Vet for 340 million eurosDechra to buy Dutch firms AST Farma, Le Vet for 340 million euros
finance.yahoo.com - January 25 at 9:08 AM
Numis Securities Reiterates "Add" Rating for Dechra Pharmaceuticals (DPH)Numis Securities Reiterates "Add" Rating for Dechra Pharmaceuticals (DPH)
www.americanbankingnews.com - January 18 at 12:58 PM
Dechra Pharmaceuticals plc (DPH) Given Consensus Rating of "Buy" by BrokeragesDechra Pharmaceuticals plc (DPH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 17 at 5:42 AM
Dechra Pharma Says Trading Strong And In Line With Management ViewDechra Pharma Says Trading Strong And In Line With Management View
www.nasdaq.com - January 10 at 5:30 PM
Dechra Pharmaceuticals plc (DPH) Given Average Rating of "Buy" by AnalystsDechra Pharmaceuticals plc (DPH) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 7 at 11:52 AM
Dechra Pharmaceuticals PLC – Value Analysis (LONDON:DPH) : December 6, 2017Dechra Pharmaceuticals PLC – Value Analysis (LONDON:DPH) : December 6, 2017
finance.yahoo.com - December 6 at 5:34 PM
Dechra Pharmaceuticals PLC breached its 50 day moving average in a Bearish Manner : DPH-GB : December 5, 2017Dechra Pharmaceuticals PLC breached its 50 day moving average in a Bearish Manner : DPH-GB : December 5, 2017
finance.yahoo.com - December 5 at 9:55 AM
ETFs with exposure to Dechra Pharmaceuticals PLC : October 26, 2017ETFs with exposure to Dechra Pharmaceuticals PLC : October 26, 2017
finance.yahoo.com - October 26 at 1:53 PM
Dechra Pharmaceuticals plc (DPH) Declares Dividend Increase - GBX 15.33 Per ShareDechra Pharmaceuticals plc (DPH) Declares Dividend Increase - GBX 15.33 Per Share
www.americanbankingnews.com - October 21 at 9:10 AM
Dechra Pharmaceuticals plc (DPH) Receives Average Recommendation of "Buy" from AnalystsDechra Pharmaceuticals plc (DPH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - October 18 at 2:50 PM
Dechra Pharmaceuticals plc (DPH) Given Consensus Recommendation of "Buy" by BrokeragesDechra Pharmaceuticals plc (DPH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 23 at 12:40 PM
Dechra Pharmaceuticals plc (DPH) Insider Ian Page Sells 54,910 SharesDechra Pharmaceuticals plc (DPH) Insider Ian Page Sells 54,910 Shares
www.americanbankingnews.com - September 20 at 1:16 PM
ETFs with exposure to Dechra Pharmaceuticals PLC : September 15, 2017ETFs with exposure to Dechra Pharmaceuticals PLC : September 15, 2017
finance.yahoo.com - September 15 at 6:26 PM
Dechra Pharmaceuticals PLC :DPH-GB: Earnings Analysis: 2017 By the Numbers : September 14, 2017Dechra Pharmaceuticals PLC :DPH-GB: Earnings Analysis: 2017 By the Numbers : September 14, 2017
finance.yahoo.com - September 14 at 12:19 AM
What Is Dechra Pharmaceuticals plc’s (LSE:DPH) Share Price Doing?What Is Dechra Pharmaceuticals plc’s (LSE:DPH) Share Price Doing?
finance.yahoo.com - September 11 at 3:43 PM
[$$] Dechra sales boosted by acquisitions and new drugs[$$] Dechra sales boosted by acquisitions and new drugs
finance.yahoo.com - September 4 at 10:43 PM
Dechra Pharmaceuticals PLC - 20 Years of Strategic GrowthDechra Pharmaceuticals PLC - 20 Years of Strategic Growth
finance.yahoo.com - September 4 at 5:40 PM
Edited Transcript of DPH.L earnings conference call or presentation 4-Sep-17 9:30am GMTEdited Transcript of DPH.L earnings conference call or presentation 4-Sep-17 9:30am GMT
finance.yahoo.com - September 4 at 5:40 PM
Dechra FY Pre-tax Profit Rises; Says Current Trading In Line With Board ViewDechra FY Pre-tax Profit Rises; Says Current Trading In Line With Board View
www.rttnews.com - September 4 at 3:30 AM
Dechra Pharmaceuticals plc (DPH) Scheduled to Post Quarterly Earnings on MondayDechra Pharmaceuticals plc (DPH) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - August 28 at 1:46 AM
Dechra Pharmaceuticals plc (DPH) Receives Average Rating of "Buy" from BrokeragesDechra Pharmaceuticals plc (DPH) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 10 at 12:49 PM
Dechra Pharmaceuticals plcs (LON:DPH) Add Rating Reaffirmed at Numis Securities LtdDechra Pharmaceuticals plc's (LON:DPH) Add Rating Reaffirmed at Numis Securities Ltd
www.americanbankingnews.com - July 9 at 9:25 AM
Dechra Pharmaceuticals plc (LON:DPH) Receives Buy Rating from N+1 SingerDechra Pharmaceuticals plc (LON:DPH) Receives Buy Rating from N+1 Singer
www.americanbankingnews.com - July 9 at 7:30 AM
Dechra Pharmaceuticals plc (LON:DPH) Earns Buy Rating from InvestecDechra Pharmaceuticals plc (LON:DPH) Earns Buy Rating from Investec
www.americanbankingnews.com - July 6 at 9:02 AM
Dechra Pharma Says FY Trading In Line With Its ViewDechra Pharma Says FY Trading In Line With Its View
www.rttnews.com - July 6 at 4:47 AM
Dechra® Pharmaceuticals PLC (LSE symbol DPH) Releases its 2017 Half-yearly Financial Report - PR Newswire (press release)Dechra® Pharmaceuticals PLC (LSE symbol DPH) Releases its 2017 Half-yearly Financial Report - PR Newswire (press release)
www.prnewswire.com - February 28 at 8:12 AM
Half Year 2017 Dechra Pharmaceuticals PLC Earnings Release - Before Market OpenHalf Year 2017 Dechra Pharmaceuticals PLC Earnings Release - Before Market Open
biz.yahoo.com - February 27 at 7:36 PM
Why I’m avoiding these exciting growth shares right nowWhy I’m avoiding these exciting growth shares right now
uk.finance.yahoo.com - February 16 at 2:55 PM
Should you make room for Pets At Home Group plc after todays update? - Yahoo Finance UKShould you make room for Pets At Home Group plc after today's update? - Yahoo Finance UK
uk.finance.yahoo.com - January 19 at 11:07 PM
Should you make room for Pets At Home Group plc after today’s update?Should you make room for Pets At Home Group plc after today’s update?
uk.finance.yahoo.com - January 19 at 6:06 PM
Does this pharmas 56% sales growth make it a better buy than GlaxoSmithKline plc? - Yahoo Finance UKDoes this pharma's 56% sales growth make it a better buy than GlaxoSmithKline plc? - Yahoo Finance UK
uk.finance.yahoo.com - January 17 at 8:22 AM
Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?
uk.finance.yahoo.com - January 17 at 8:22 AM

SEC Filings

Dechra Pharmaceuticals (LON:DPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Dechra Pharmaceuticals (LON DPH) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.